Terms: = Colorectal cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Staging
12 results:
1. Epidemiological and molecular evaluation of BRAF, KRAS, nras genes and MSI in the development of colorectal cancer.
Paula Simedan Vila A; Helena Rodrigues G; Leite Marzochi L; Garcia de Oliveira-Cucolo J; Lívia Silva Galbiatti-Dias A; Felipe Maciel Andrade R; de Santi Neto D; Gomes Netinho J; Castiglioni L; Cristina Pavarino É; Maria Goloni-Bertollo E
Gene; 2023 Jun; 870():147395. PubMed ID: 36990254
[TBL] [Abstract] [Full Text] [Related]
2. The relationships of OSBPL3 expression with KI-67 expression and KRAS mutations in CRC: implications for diagnosis and prognosis.
Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
[TBL] [Abstract] [Full Text] [Related]
3. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
[TBL] [Abstract] [Full Text] [Related]
4. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract] [Full Text] [Related]
5. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features.
Nagarajan P; Piao J; Ning J; Noordenbos LE; Curry JL; Torres-Cabala CA; Diwan AH; Ivan D; Aung PP; Ross MI; Royal RE; Wargo JA; Wang WL; Samdani R; Lazar AJ; Rashid A; Davies MA; Prieto VG; Gershenwald JE; Tetzlaff MT
Mod Pathol; 2020 Mar; 33(3):496-513. PubMed ID: 31383963
[TBL] [Abstract] [Full Text] [Related]
7. Mucinous Adenocarcinomas Histotype Can Also be a High-Risk Factor for Stage II colorectal cancer Patients.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai S
Cell Physiol Biochem; 2018; 47(2):630-640. PubMed ID: 29794464
[TBL] [Abstract] [Full Text] [Related]
8. Can CT-based radiomics signature predict KRAS/nras/BRAF mutations in colorectal cancer?
Yang L; Dong D; Fang M; Zhu Y; Zang Y; Liu Z; Zhang H; Ying J; Zhao X; Tian J
Eur Radiol; 2018 May; 28(5):2058-2067. PubMed ID: 29335867
[TBL] [Abstract] [Full Text] [Related]
9. Molecular and Clinicopathological Differences by Age at the Diagnosis of colorectal cancer.
Chang CC; Lin PC; Lin CC; Lan YT; Lin HH; Lin CH; Yang SH; Liang WY; Chen WS; Jiang JK; Lin JK; Chang SC
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678173
[TBL] [Abstract] [Full Text] [Related]
10. [Improvement of prognostic and predictive network of colorectal cancer based upon the 8th edition of AJCC colorectal cancer staging system].
Yao H; Wu H; Liu Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):24-27. PubMed ID: 28105615
[TBL] [Abstract] [Full Text] [Related]
11. High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in colorectal cancer.
Jeantet M; Tougeron D; Tachon G; Cortes U; Archambaut C; Fromont G; Karayan-Tapon L
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916952
[TBL] [Abstract] [Full Text] [Related]
12. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract] [Full Text] [Related]